Andreas Gerber
Chief Operating Officer at APEIRON Biologics AG
Andreas Gerber active positions
| Companies | Position | Start | End |
|---|---|---|---|
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Chief Operating Officer | 2021-05-31 | - |
Career history of Andreas Gerber
Training of Andreas Gerber
| University of Basel | Doctorate Degree |
| University of St. Gallen | Masters Business Admin |
Statistics
International
| Switzerland | 3 |
| Austria | 2 |
Operational
| Chief Operating Officer | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Stock Market
- Insiders
- Andreas Gerber
- Experience
